Treatment for Amblyopia Using CureSight Technology
Treating Amblyopia With CureSight
This study is testing a new device called CureSight to see if it can help children and teens with amblyopia improve their vision.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 2 Years to 20 Years |
| Sex | All |
| Sponsor | Alaska Blind Child Discovery Academic / other |
| Locations | 1 site (Anchorage, Alaska) |
| Trial ID | NCT06165705 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the efficacy of the CureSight device in treating amblyopia in patients aged 3 to 19 years. Participants will use the CureSight device for 1.5 hours daily, six days a week, over a period of 3 to 6 months. The device employs eye-tracking technology to present tailored visual stimuli to each eye, promoting improved visual acuity. Patients will be recruited from the Alaska Children's EYE & Strabismus clinical practice and will undergo various visual acuity tests throughout the treatment period.
Who should consider this trial
Good fit: Ideal candidates are children aged 3 to less than 19 years diagnosed with amblyopia due to refractive error, strabismus, or deprivation.
Not a fit: Patients who cannot participate in visual acuity testing or lack internet access at home may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve visual acuity in children suffering from amblyopia.
How similar studies have performed: Previous studies using similar dichoptic treatment approaches have shown promising results in improving amblyopia outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * amblyopia Exclusion Criteria: * lack of brain and eye capacity for improved vision lack of home WiFi
Where this trial is running
Anchorage, Alaska
- Alaska Blind Child Discovery — Anchorage, Alaska, United States (Recruiting)
Study contacts
- Principal investigator: Robert W Arnold, MD — Alaska Blind Child Discovery
- Study coordinator: Robert W Arnold, MD
- Email: eyedoc@alaska.net
- Phone: 9075611917
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.